According to Silence Therapeutics's latest financial reports the company has $68.78 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $68.78 M | -20.23% |
2022-12-31 | $86.22 M | -13.13% |
2021-12-31 | $99.26 M | 94.46% |
2020-12-31 | $51.04 M | 16.15% |
2019-12-31 | $43.94 M | 30.47% |
2018-12-31 | $33.68 M | -42.13% |
2017-12-31 | $58.2 M | 20.82% |
2016-12-31 | $48.17 M | -37.37% |
2015-12-31 | $76.92 M | 126.05% |
2014-12-31 | $34.02 M | -1.25% |
2013-12-31 | $34.45 M | 139.3% |
2012-12-31 | $14.39 M | 151.7% |
2011-12-31 | $5.72 M | 3.92% |
2010-12-31 | $5.5 M | 200.78% |
2009-12-31 | $1.83 M | -62.72% |
2008-12-31 | $4.9 M | -75.71% |
2007-12-31 | $20.21 M | 16.61% |
2006-12-31 | $17.33 M | 10.9% |
2005-12-31 | $15.62 M | 209.31% |
2004-12-31 | $5.05 M | -44.54% |
2003-12-31 | $9.11 M | 1.44% |
2002-12-31 | $8.98 M | -21.12% |
2001-12-31 | $11.38 M |